BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

712 related articles for article (PubMed ID: 28367149)

  • 1. Major Histocompatibility Complex (MHC) Class I and MHC Class II Proteins: Conformational Plasticity in Antigen Presentation.
    Wieczorek M; Abualrous ET; Sticht J; Álvaro-Benito M; Stolzenberg S; Noé F; Freund C
    Front Immunol; 2017; 8():292. PubMed ID: 28367149
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Role of Molecular Flexibility in Antigen Presentation and T Cell Receptor-Mediated Signaling.
    Natarajan K; Jiang J; May NA; Mage MG; Boyd LF; McShan AC; Sgourakis NG; Bax A; Margulies DH
    Front Immunol; 2018; 9():1657. PubMed ID: 30065727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proofreading of Peptide-MHC Complexes through Dynamic Multivalent Interactions.
    Thomas C; Tampé R
    Front Immunol; 2017; 8():65. PubMed ID: 28228754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A loop structure allows TAPBPR to exert its dual function as MHC I chaperone and peptide editor.
    Sagert L; Hennig F; Thomas C; Tampé R
    Elife; 2020 Mar; 9():. PubMed ID: 32167472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C Molecules.
    Altenburg AF; Morley JL; Bauer J; Walz JS; Boyle LH
    Wellcome Open Res; 2024; 9():113. PubMed ID: 38800518
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Achieving stability through editing and chaperoning: regulation of MHC class II peptide binding and expression.
    Busch R; Rinderknecht CH; Roh S; Lee AW; Harding JJ; Burster T; Hornell TM; Mellins ED
    Immunol Rev; 2005 Oct; 207():242-60. PubMed ID: 16181341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-II dynamics are maintained in HLA-DR allotypes to ensure catalyzed peptide exchange.
    Abualrous ET; Stolzenberg S; Sticht J; Wieczorek M; Roske Y; Günther M; Dähn S; Boesen BB; Calvo MM; Biese C; Kuppler F; Medina-García Á; Álvaro-Benito M; Höfer T; Noé F; Freund C
    Nat Chem Biol; 2023 Oct; 19(10):1196-1204. PubMed ID: 37142807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular architecture of the MHC I peptide-loading complex: one tapasin molecule is essential and sufficient for antigen processing.
    Hulpke S; Baldauf C; Tampé R
    FASEB J; 2012 Dec; 26(12):5071-80. PubMed ID: 22923333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [MHC tetramers: tracking specific immunity].
    Kosor E; Gagro A; Drazenović V; Kuzman I; Jeren T; Rakusić S; Rabatić S; Markotić A; Gotovac K; Sabioncello A; Cecuk E; Kerhin-Brkljacić V; Gjenero-Margan I; Kaić B; Mlinarić-Galinović G; Kastelan A; Dekaris D
    Acta Med Croatica; 2003; 57(4):255-9. PubMed ID: 14639858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural Insights Into HLA-DM Mediated MHC II Peptide Exchange.
    Painter CA; Stern LJ
    Curr Top Biochem Res; 2011; 13(2):39-55. PubMed ID: 25264402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Processing of MHC class I presented antigens].
    van Endert P
    Med Sci (Paris); 2006; 22(8-9):727-32. PubMed ID: 16962047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Editing of the HLA-DR-peptide repertoire by HLA-DM.
    Kropshofer H; Vogt AB; Moldenhauer G; Hammer J; Blum JS; Hämmerling GJ
    EMBO J; 1996 Nov; 15(22):6144-54. PubMed ID: 8947036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-Allelic Model for Prediction of Peptide:MHC-II Interactions.
    Degoot AM; Chirove F; Ndifon W
    Front Immunol; 2018; 9():1410. PubMed ID: 29988560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loading dynamics of one SARS-CoV-2-derived peptide into MHC-II revealed by kinetic models.
    Song K; Xu H; Da LT
    Biophys J; 2023 May; 122(9):1665-1677. PubMed ID: 36964657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DM and DO shape the repertoire of peptide-MHC-class-II complexes.
    Karlsson L
    Curr Opin Immunol; 2005 Feb; 17(1):65-70. PubMed ID: 15653313
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amino acid substitutions at position 97 in HLA-A2 segregate cytolysis from cytokine release in MART-1/Melan-A peptide AAGIGILTV-specific cytotoxic T lymphocytes.
    Maeurer MJ; Chan HW; Karbach J; Salter RD; Knuth A; Lotze MT; Storkus WJ
    Eur J Immunol; 1996 Nov; 26(11):2613-23. PubMed ID: 8921947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tapasin enhances MHC class I peptide presentation according to peptide half-life.
    Howarth M; Williams A; Tolstrup AB; Elliott T
    Proc Natl Acad Sci U S A; 2004 Aug; 101(32):11737-42. PubMed ID: 15286279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Other Function: Class II-Restricted Antigen Presentation by B Cells.
    Adler LN; Jiang W; Bhamidipati K; Millican M; Macaubas C; Hung SC; Mellins ED
    Front Immunol; 2017; 8():319. PubMed ID: 28386257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. T cell receptor/peptide/MHC molecular characterization and standardized pMHC contact sites in IMGT/3Dstructure-DB.
    Kaas Q; Lefranc MP
    In Silico Biol; 2005; 5(5-6):505-28. PubMed ID: 16268793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.